To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Multimodal Injection for Postoperative Pain Control in Pediatric Patients With Cerebral Palsy

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
February 2025

Multimodal Injection for Postoperative Pain Control in Pediatric Patients With Cerebral Palsy

Vol: 307| Issue: 2| Number:50| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Efficacy of a Multimodal Surgical Site Injection for Postoperative Pain Control in Pediatric Patients With Cerebral Palsy Undergoing Hip Reconstruction: A Randomized Controlled Trial.

J Pediatr Orthop . 2024 Nov-Dec;44(10):e921-e928.

Contributing Authors:
D Greig CA Sun D McBride B Young A Klomhaus VT Swaroop RM Thompson

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Thirty-four pediatric patients with cerebral palsy undergoing hip reconstruction were randomized to receive either a multimodal surgical site injection containing ropivacaine (3 mg/kg), epinephrine (0.5 mg), and ketorolac (0.5 mg/kg) (n=17) or a placebo injection of normal saline (n=17). The primary outcome of interest was total narcotic consumption, measured in morphine equivalents per kilogram (...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue